NIHR Leeds BRC hosts joint International Clinical Trials Day 2025 event
NIHR Leeds BRC hosted a joint event to celebrate International Clinical Trials Day, highlighting the role trials play in advancing medical research and …
NIHR Leeds BRC hosted a joint event to celebrate International Clinical Trials Day, highlighting the role trials play in advancing medical research and …
The fourth instalment of the Moving Forward Infection Diagnostics event series recently took place at Nexus Leeds, drawing leading voices from across the healthcare and diagnostics sectors for a day of collaboration, insight, and innovation.
A national clinical trial supported by the NIHR Leeds Biomedical Research Centre has demonstrated that a novel combination of targeted therapies can extend remission and improve quality of life for patients with relapsed myeloma, a blood cancer that accounts for 1 in every 50 new cancer diagnoses in the UK.
As we mark Vasculitis Awareness Month, we are proud to share that NIHR Leeds BRC has partnered with Leeds Institute for Data Analytics (LIDA) on a new data study on giant cell arthritis (GCA), as part of a programme to foster talent in upcoming data scientists.
Our colleague, Professor Francesco Del Gado, has had a collaborative study on systemic sclerosis with Yale University published in The Lancet Rheumatology.
Our colleague Professor Paul Emery CBE has been ranked as the number 1 immunologist in the UK and 21 in the world by a leading academic platform for researchers. He was also recognised with the Immunology Leader Award for 2025.
Congratulations to our colleagues Professor Helena Marzo-Ortega, Dr Jane Freeston and Dr Christian Sellinger who have all been recognised by the National Axial Sponyloarthritis Society (NASS) for their outstanding contributions to improving the care of patients living with this condition.
Join us for a two-day course on Giant Cell Arteritis (GCA)
Save the date: Thursday 9th & Friday 10th October
GPs can more accurately identify older people’s frailty and intervene earlier as a result of NIHR-funded research.
A tiny magnetic robot which can take 3D scans from deep within the body, that could revolutionising early cancer detection, has been developed with NIHR Leeds BRC supported research.